GENGF yields 12.01% · JNJ yields 2.13%● Live data
📍 GENGF pulled ahead of the other in Year 1
Combined, GENGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GENGF + JNJ for your $10,000?
Gear Energy Ltd., an exploration and production company, acquires, develops, and holds interests in petroleum and natural gas properties and assets in Canada. Its properties include the Celtic/Paradise Hill property located approximately 40 kilometers northeast of Lloydminster Alberta; the Wildmere field situated approximately 200 kilometers southeast of Edmonton, Alberta; the Wilson Creek property located in Central Alberta; and the Tableland property situated southwest of Estevan in Southeast Saskatchewan. As of December 31, 2021, the company's Celtic/Paradise Hill property had proved plus probable reserves of 4,047 thousand barrels (Mbbls) of heavy crude oil; the Wildmere field had proved plus probable reserves of 3,405 Mbbls of heavy crude oil and 1.4 billion cubic feet (Bcf) of natural gas; the Wilson Creek property comprised of proved plus probable reserves of 3,318 Mbbls of light crude oil and natural gas liquids (NGLs), and 6.2 Bcf of natural gas; and the Tableland property had proved plus probable reserves of 5,315 Mbbls of light crude oil and NGLs, and 3.5 BCF of natural gas. Gear Energy Ltd. is headquartered in Calgary, Canada.
Full GENGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.